Giorgia Grosso

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cardiovascular magnetic resonance as an initial screening tool in individuals with SLE and chest pain.

Cardiovascular magnetic resonance as an initial screening tool in individuals with SLE and chest pain.

Journal: Lupus science & medicine

Published: April 30, 2025

Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials.

Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials.

Journal: Rheumatology (Oxford, England)

Published: December 16, 2024

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB113 and negatively with HLA-DRB103 in SLE.

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB113 and negatively with HLA-DRB103 in SLE.

Journal: Rheumatology (Oxford, England)

Published: February 19, 2022

Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.

Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE.

Journal: Lupus

Published: May 07, 2021

The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies.

The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies.

Journal: Thrombosis and haemostasis

Published: January 07, 2021

Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?

Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?

Journal: Diabetes & vascular disease research

Published: June 09, 2020

Contributions of de novo variants to systemic lupus erythematosus.

Contributions of de novo variants to systemic lupus erythematosus.

Journal: European journal of human genetics : EJHG

Published: January 16, 2020

Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus.

Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus.

Journal: Rheumatology (Oxford, England)

Published: November 13, 2019

Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients.

Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients.

Journal: Frontiers in immunology

Published: December 14, 2018

Antiphospholipid Antibodies in Patients With Myocardial Infarction.

Antiphospholipid Antibodies in Patients With Myocardial Infarction.

Journal: Annals of internal medicine

Published: October 26, 2018

Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus.

Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus.

Journal: Human genetics

Published: October 01, 2018

Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.

Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.

Journal: Arthritis research & therapy

Published: September 03, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026